ABSTRACT OBJECTIVES This study sought to describe the development of a multicenter, transcatheter aortic valve replacement program and regional systems of care intended to optimize coordinated, efficient, and appropriate delivery of this new therapy.
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Stub et al. The 30-day all-cause mortality was 3.5%. Inhospital patient outcomes are presented in Table 3 .
All-cause in-hospital mortality occurred in 3.1%.
Disabling stroke occurred in 1.9% and myocardial infarction in 0.9%. Major vascular complications were reported in 2.2% of patients, with 8.1% experiencing a major bleeding complication. Analysis of patients according to access site revealed lower mortality in TF cases (2.6%) compared with non-TF cases (6.0%).
Similarly disabling stroke (1.6% vs. 3.6%) and major bleeding (6.8% vs. 15.5%) were lower in TF implants.
Moderate paravalvular regurgitation was seen in Values are median (interquartile range) or n (%). Values are median (interquartile range) or n (%).
AVR ¼ aortic valve replacement; CKD ¼ chronic kidney disease; COPD ¼ chronic obstruction pulmonary disease; LVEF ¼ left ventricular ejection fraction; NYHA ¼ New York Heart Association; STS PROM ¼ Society of Thoracic Surgeons predicted risk of mortality. Values are N, median (range), mean AE SD, or %. *Length of stay not stratified according to access. †In-hospital mortality and stroke. ‡In-hospital stroke.
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BC ¼ British Columbia; GARY ¼ German Aortic Valve Registry; TAVI ¼ transcatheter aortic valve implantation; THV ¼ transcatheter heart valve. Stub et al.
Regional Systems for TAVR Values are N, median (range), mean AE SD, or %. *Length of stay not stratified according to access. †In-hospital mortality and stroke. ‡In-hospital stroke.
Abbreviations as in Table 4 .
consensus treatment decisions, appropriate access route and device selection, and post-procedural care.
Our reported short hospital stays with over 90% of patients being discharged home is indicative of the health service benefits of a regional approach to TAVR care. Although these metrics are infrequently reported in international registries, these measures will become increasingly important in real word practice as TAVR expands into lower-risk populations, where quality of life, program efficiencies, and costs will be important determinants of expanding programs. 
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